Chlorpromazine Phenolphthalinate

氯丙嗪酚酞酸盐

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChlorpromazine Phenolphthalinate
Drug Alias Name酚酞氯丙嗪Wintermin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsAdrenergic receptors alpha-2 antagonistsHistamine receptor antagonists
TargetsAdrenergic receptors alpha-2Histamine receptorDopamine D2 receptor
Therapy Area/IndicationsSedationSchizophreniaBipolar Disorder +[8] 
Global Approved IndicationsSedationSchizophreniaBipolar Disorder +[8] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1977/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSedationSchizophreniaBipolar Disorder +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN05AA01
Related LinksWikipediaDrugBankKEGG